US FDA head Hamburg declares no one can inspect world on its own
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.